Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (67)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- Chronic inflammation combines three simultaneous processes
- Inflammatory and resident macrophages: Origins differ
- Activated macrophages deploy microbicidal effectors
- T-cell subsets deliver different macrophage signals
- Alternatively activated macrophages promote repair
- The injury–repair balance determines tissue outcome
- Silica exposure: The problem of a persistent particle
- Reference
Slide index & full transcript (67 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Role of Macrophages
Origins • activation • chronic inflammation • tissue repair
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning outcomes: Explain what macrophages do
Identify developmental sources and tissue-specific macrophage populations.
Explain recruitment, activation and effector functions in chronic inflammation.
Connect macrophage–T cell signaling to tissue injury, repair and granulomas.
Lineage and recruitment
Activation and effector functions
Pathologic outcomes
SCHEMATIC
Slide 3 · Chronic inflammation combines three simultaneous processes
Prolonged inflammation often continues for weeks or months.
Tissue injury coexists with the cellular inflammatory response.
Healing reactions occur at the same site, frequently with fibrosis.
Inflammation
Tissue injury
Repair / fibrosis
SCHEMATIC
Slide 4 · Why chronic inflammation persists
Persistent microbes resist elimination and maintain inflammatory stimulation.
Inappropriate immune reactions can amplify injury against self or environmental antigens.
Nondegradable or toxic material may provide a continuing stimulus.
Resistant microorganisms
Immune dysregulation
Toxic / inert particles
Persistent stimulus
SCHEMATIC
Slide 5 · The histologic triad of chronic inflammation
Mononuclear infiltrates include macrophages, lymphocytes and plasma cells.
Tissue destruction results from the agent, inflammatory cells, or both.
Angiogenesis and connective-tissue deposition mark attempted healing.
Mononuclear cells
Parenchymal injury
Fibrosis / angiogenesis
SCHEMATIC
Slide 6 · Macrophages are central—not merely scavengers
They eliminate microbes and damaged tissues by phagocytosis.
They secrete cytokines and growth factors that change neighboring cell behavior.
They communicate with T lymphocytes and organize the tissue response.
Removal
Inflammation
T-cell activation
Repair
Macrophage
SCHEMATIC
Slide 7 · One cell population can protect and damage tissue
Microbicidal products support host defense.
Excessive or inappropriate activation can injure normal tissue.
Growth factors also initiate the repair response after injury.
Eliminate danger
Collateral injury
Coordinate repair
SCHEMATIC
Slide 8 · The mononuclear phagocyte system
Monocytes are circulating cells of the macrophage lineage.
Macrophages are resident or recruited tissue phagocytes.
The historical term “reticuloendothelial system” is imprecise.
Circulating monocyte
Tissue macrophage
Phagocytosis and signaling
SCHEMATIC
Slide 9 · Two developmental routes contribute macrophages
Hematopoietic stem cells in bone marrow generate circulating monocytes.
Embryonic yolk sac and fetal liver provide precursors to selected resident populations.
Origin depends on tissue and inflammatory context.
Postnatal pathway
Bone marrow stem cell
Blood monocyte
Inflammatory macrophage
Embryonic pathway
Yolk sac / fetal liver
Early tissue seeding
Long-lived resident pool
SCHEMATIC
Slide 10 · Bone marrow-derived macrophage development
Committed marrow precursors produce monocytes.
Monocytes enter blood before crossing vascular endothelium.
Differentiation within tissues yields macrophages.
Marrow progenitor
Blood monocyte
Tissue entry
Macrophage
SCHEMATIC
Slide 11 · Embryonic precursors establish resident populations
Progenitors arise early in the yolk sac or fetal liver.
They enter developing organs and establish tissue macrophage populations.
Some resident populations are maintained long term.
Yolk sac / fetal liver
Developing organ
Resident macrophage
SCHEMATIC
Slide 12 · Inflammatory and resident macrophages: Origins differ
Inflamed tissues often contain recruited monocyte-derived macrophages.
The brain, liver and lung contain populations seeded during development.
A tissue label does not by itself identify the origin of every macrophage in disease.
Inflammatory influx
Blood monocytes
Endothelial emigration
Tissue differentiation
Tissue residence
Early organ colonization
Established tissue pool
Long-term persistence
SCHEMATIC
Slide 13 · Different organs assign different macrophage names
Location
Macrophage name
Liver
Kupffer cell
Brain / CNS
Microglia
Lung alveolus
Alveolar macrophage
Spleen / lymph-node sinuses
Sinus histiocyte
Kupffer cells are liver macrophages.
Microglia are macrophages in the central nervous system.
Alveolar macrophages reside in the lung; Sinus histiocytes occur in lymphoid organs.
Slide 14 · Macrophages are also dispersed in connective tissues
They are present beyond specialized organ compartments.
Skin and intestinal tissues can receive monocyte-derived macrophages.
Location and recent recruitment together shape local macrophage composition.
Connective tissue
Skin
Intestinal tract
Specialized organs
Tissue macrophages
SCHEMATIC
Slide 15 · Monocytes and macrophages have different kinetics
Blood monocytes have an approximate half-life of one day in the cited text.
Tissue macrophages may survive for months to years.
This difference permits prolonged local macrophage activity.
Blood monocytes
Circulating compartment
Approx. 1-day half-life
Source for tissue influx
Tissue macrophages
Extravascular compartment
Months–years lifespan possible
Persistent local effector functions
SCHEMATIC
Slide 16 · Macrophages can dominate after the early response
Monocytes begin entering inflamed tissues relatively early.
Within about 48 hours, macrophages may become the predominant cell type.
Timing is a pattern, not a universal diagnostic cutoff.
Early acute response
Monocyte entry
Macrophage-rich infiltrate
SCHEMATIC
Slide 17 · How monocytes reach injured tissue
The processes depend on endothelial adhesion molecules.
Chemotactic factors guide monocytes toward the inflammatory stimulus.
After exiting blood, monocytes differentiate into tissue macrophages.
Vascular adhesion
Extravasation
Chemotaxis
Differentiation
SCHEMATIC
Slide 18 · Two processes can maintain macrophage accumulation
Continued recruitment replenishes macrophages from the circulation.
Local macrophage proliferation can enlarge the tissue population.
Persistent accumulation helps maintain chronic inflammation.
Continuous recruitment
Local proliferation
Tissue persistence
Macrophage pool
SCHEMATIC
Slide 19 · Macrophages may disappear after the stimulus resolves
Removal of the irritant permits the inflammatory response to subside.
Some macrophages die; Others depart through lymphatics and lymph nodes.
Failure to remove the stimulus favors persistence.
Stimulus eliminated
Inflammation subsides
Death or lymphatic exit
Less macrophage accumulation
Stimulus persists
Ongoing recruitment
Possible local proliferation
Sustained macrophage activation
SCHEMATIC
Slide 20 · Phagocytosis removes microbes and dead tissue
Macrophages are professional phagocytes.
Targets include infectious agents and necrotic cellular material.
Clearance is both defensive and preparatory for repair.
Microbe / debris
Engulfment
Intracellular destruction
Cleaner tissue bed
SCHEMATIC
Slide 21 · Activated macrophages deploy microbicidal effectors
Classically activated macrophages produce reactive oxygen species (ROS).
Nitric oxide (NO) contributes to microbial killing.
Lysosomal enzymes digest material taken into phagocytic compartments.
ROS
NO
Lysosomal enzymes
Microbial killing
SCHEMATIC
Slide 22 · The same effector products can injure host tissue
ROS, NO and enzymes are useful in antimicrobial defense.
Excess activation can damage normal tissue components.
Collateral destruction explains part of the morphology of chronic inflammation.
Sustained activation
Toxic mediators
Host tissue injury
SCHEMATIC
Slide 23 · Macrophages transmit inflammation by cytokines
Tumor necrosis factor (TNF) and interleukin-1 (IL-1) are examples.
Chemokines direct additional leukocyte recruitment.
These mediators help initiate and propagate inflammatory reactions.
TNF
IL-1
Chemokines
Activated macrophage
SCHEMATIC
Slide 24 · Chemokines reinforce leukocyte recruitment
Activated macrophages contribute chemotactic mediator signals.
Newly arriving leukocytes can expand the inflammatory infiltrate.
Recruitment creates a potential positive feedback mechanism.
Macrophage activation
Chemokines
Leukocyte influx
Continued inflammation
↺ Reinforcing feedback
SCHEMATIC
Slide 25 · Eicosanoids add another mediator class
Macrophages can generate eicosanoid inflammatory mediators.
They act alongside protein mediators such as cytokines.
Macrophage influence therefore extends beyond direct phagocytosis.
Protein mediators
TNF
IL-1
Chemokines
Lipid mediators
Eicosanoids
Act with cytokines
Inflammatory signaling
SCHEMATIC
Slide 26 · Macrophage-derived signals have distinct recipients
Leukocytes respond to recruitment and activation mediators.
T lymphocytes respond to antigen presentation and cytokines.
Fibroblasts and reparative cells respond to growth factors.
Recruited leukocytes
T lymphocytes
Fibroblasts / repair cells
Macrophage signals
SCHEMATIC
Slide 27 · Antigen presentation links innate and adaptive responses
Macrophages display antigens to T lymphocytes.
Costimulatory molecules participate in T-cell activation.
Inflammatory cytokines, including IL-12, strengthen this communication.
Antigen-bearing macrophage
T-cell recognition
Activated T cell
SCHEMATIC
Slide 28 · Macrophages and T cells activate one another
Macrophages present antigen and secrete T-cell-stimulating cytokines.
Activated T cells secrete macrophage-activating signals.
This bidirectional circuit sustains chronic inflammation.
Antigen presentation
T-cell activation
IFN-γ and cytokines
Macrophage activation
↺ Reinforcing feedback
SCHEMATIC
Slide 29 · IL-12 is part of the macrophage-to-T-cell arm
Activated macrophages can produce IL-12.
Along with antigen display and costimulation, IL-12 supports T-cell responses.
The responding T cells can further influence macrophage behavior.
Macrophage
Antigen + IL-12
T-cell response
Macrophage signals
SCHEMATIC
Slide 30 · T-cell subsets deliver different macrophage signals
T-cell setting
Principal signal
Relevant result
Th1
IFN-γ
Classical macrophage activation
Th2
IL-4 / IL-13
Alternative activation
Th17
IL-17-linked chemokines
Leukocyte recruitment
Th1 cells generate IFN-γ, promoting classical activation.
Th2-associated IL-4 and IL-13 promote alternative activation.
Th17-driven chemokine pathways favor further neutrophil and monocyte recruitment.
Slide 31 · Activation states reflect external signals
Different stimuli change macrophage effector programs.
Classical and alternative activation as broad pathways.
These are conceptual poles rather than exhaustive cell subsets.
Classical / M1-like
Microbial products
IFN-γ / foreign material
Killing + inflammation
Alternative / M2-like
IL-4 / IL-13
Resolution and repair
Less microbicidal emphasis
SCHEMATIC
Slide 32 · Classical activation has several initiating stimuli
Microbial endotoxin engages toll-like receptors (TLRs) and related sensors.
IFN-γ supplied by T cells is a major immune signal.
Crystals and particulate material may also induce classical activation.
Microbial products / TLRs
Th1-derived IFN-γ
Crystals / particles
Classical activation
SCHEMATIC
Slide 33 · Microbial sensing promotes classical activation
Bacterial products are detected by innate immune receptors such as TLRs.
Activation boosts microbicidal machinery and inflammatory mediator release.
The response is useful when a microbial threat must be destroyed.
Microbial material
TLR sensing
Classical activation
Microbial killing
SCHEMATIC
Slide 34 · IFN-γ bridges Th1 immunity and macrophage killing
Th1 cells produce interferon-γ (IFN-γ).
IFN-γ strongly activates macrophages by the classical pathway.
This signaling underlies important cell-mediated immune defenses.
Activated Th1 cell
IFN-γ
Macrophage activation
Microbial defense
SCHEMATIC
Slide 35 · Particulate matter can drive macrophage activation
Crystals and inert particles may stimulate macrophages.
Exposure can continue when material is difficult to degrade or clear.
Persistent stimulation can link macrophage activation to chronic injury.
Persistent particle
Macrophage activation
Continued inflammatory response
SCHEMATIC
Slide 36 · Classically activated cells emphasize destruction
NO and ROS enhance microbial killing.
Lysosomal enzymes destroy ingested material.
Inflammatory cytokines amplify host recruitment and activation.
Reactive species
Lysosomal enzymes
Inflammatory cytokines
SCHEMATIC
Slide 37 · ROS and NO illustrate the defense–injury tradeoff
Both reactive species are part of the macrophage microbicidal arsenal.
Production helps eliminate pathogens.
Inappropriately sustained release can contribute to tissue damage.
Beneficial setting
Controlled activation
Pathogen elimination
Host protection
Pathologic setting
Excessive activation
Collateral cellular injury
Chronic tissue destruction
SCHEMATIC
Slide 38 · Classical activation can prolong inflammation
Classically activated macrophages secrete inflammatory cytokines.
Additional cell recruitment increases the number of active leukocytes.
Persistent stimulation can maintain a destructive tissue microenvironment.
Stimulus persists
M1-like mediators
Recruitment
Persistent injury
↺ Reinforcing feedback
SCHEMATIC
Slide 39 · Alternative activation is induced by IL-4 and IL-13
IL-4 and IL-13 can be released by T lymphocytes and other cells.
These signals promote an alternative macrophage program.
The pathway contrasts with IFN-γ-driven classical activation.
IL-4 / IL-13
Alternative activation
Resolution / repair
SCHEMATIC
Slide 40 · Alternatively activated macrophages promote repair
They are relatively less focused on direct microbial killing.
They help dampen or terminate inflammatory responses.
They stimulate tissue repair programs after injury.
Inflammation resolution
Repair signaling
Tissue remodeling
SCHEMATIC
Slide 41 · M1-like versus M2-like: A functional comparison
Dimension
M1-like / classical
M2-like / alternative
Typical inducer
TLR signals; IFN-γ
IL-4; IL-13
Strongest emphasis
Killing and inflammation
Resolution and repair
Characteristic outputs
NO, ROS, cytokines
Reparative mediators
Clinical tension
Microbe killing vs injury
Healing vs fibrosis
The categories summarize different stimulus–response patterns.
Neither class describes every macrophage in a real lesion.
Interpret phenotype by function and local signals, not a single absolute label.
Slide 42 · The M1–M2 dichotomy is an imperfect model
Intermediate phenotypes exist between the two textbook extremes.
There are no precise defining markers for all macrophage states.
“M1-like” and “M2-like” better convey a continuum of activation.
Inflammatory-biased
Intermediate states
Reparative-biased
SCHEMATIC
Slide 43 · Macrophage phenotypes can coexist in one lesion
Inflammatory reactions may contain several activation states at once.
A clean sequence of M1 then M2 is plausible but not usually demonstrated.
Never infer an obligatory temporal switch from a single histologic field.
Oversimplified narrative
M1 first
M2 second
One-way switch
Textbook qualification
Phenotypes may overlap
Intermediate states common
Timing is not assured
SCHEMATIC
Slide 44 · Macrophages initiate tissue repair
Phagocytosis removes dead tissue and injurious material.
Growth factors produced by activated macrophages stimulate local cell proliferation.
The same cellular response that fights injury can help rebuild tissue.
Injury and debris
Macrophage response
Growth factors
Repair-cell proliferation
SCHEMATIC
Slide 45 · Growth factors connect macrophages to regeneration
Activated macrophages are major growth-factor sources at injured sites.
Growth factors act on surviving parenchymal and stromal cells.
Regeneration also depends on tissue proliferative capacity and intact ECM.
Surviving tissue cells
Endothelial cells
Fibroblasts
Growth factors
SCHEMATIC
Slide 46 · Fibrosis is one possible outcome of sustained repair
Macrophage- and lymphocyte-derived cytokines activate fibroblasts.
Fibroblasts and myofibroblasts deposit extracellular matrix (ECM).
When tissue architecture is lost, connective tissue replaces damaged parenchyma.
Persistent injury
Macrophage cytokines
Fibroblast response
Collagen / fibrosis
SCHEMATIC
Slide 47 · TGF-β has a central fibrogenic role
Transforming growth factor-β (TGF-β) is a potent driver of fibrosis.
It helps promote ECM accumulation during repair.
In persistent injury, reparative signaling may produce excessive scarring.
Macrophage-associated repair signals
TGF-β activity
ECM deposition
Scar
SCHEMATIC
Slide 48 · Scar remodeling requires matrix turnover
Matrix metalloproteinases (MMPs) digest ECM constituents.
Macrophages are one of several cellular sources of MMPs.
Tissue inhibitors of metalloproteinases (TIMPs) restrain enzyme activity.
ECM synthesis
MMP-mediated degradation
TIMP inhibition
SCHEMATIC
Slide 49 · The injury–repair balance determines tissue outcome
Effective removal of the stimulus favors resolution.
Continuing inflammation drives ongoing damage and repair signaling.
Fibrosis becomes important when normal architecture cannot be restored.
Resolution favored
Offending agent removed
Macrophage decline
Repair completes
Fibrosis favored
Persistent injury
Continued cytokine output
Collagen accumulation
SCHEMATIC
Slide 50 · Chronic lesions combine damage and healing
Activated macrophages are a source of tissue-destructive products.
Other macrophage outputs stimulate fibroblasts and angiogenic repair.
Both effects can be present within the same chronic lesion.
Destructive products
Growth factors
Persistent macrophages
SCHEMATIC
Slide 51 · Granulomas represent organized macrophage-rich responses
Granulomatous inflammation contains collections of activated macrophages.
T lymphocytes are often present; Necrosis may occur.
Organization attempts to contain agents difficult to eradicate.
Persistent offending agent
Macrophage activation
Cellular aggregation
Granuloma
SCHEMATIC
Slide 52 · Epithelioid cells are activated macrophages
Activated macrophages may gain abundant cytoplasm.
Their appearance can resemble epithelial cells, hence “epithelioid.”
This is a morphologic response, not epithelial lineage conversion.
Ordinary macrophage
Mononuclear phagocyte
Active uptake and signaling
Epithelioid macrophage
Abundant cytoplasm
Clustered in granuloma
SCHEMATIC
Slide 53 · Multinucleated giant cells arise by macrophage fusion
Some activated macrophages fuse into multinucleate giant cells.
Giant cells may occur around foreign material or within immune granulomas.
Their presence must be interpreted within the full lesion context.
Activated macrophages
Cell fusion
Multinucleated giant cell
SCHEMATIC
Slide 54 · Foreign-body and immune granulomas differ mechanistically
Foreign-body granulomas form against material too large for phagocytosis.
Immune granulomas result from persistent T-cell-mediated responses.
Both contain macrophage-derived epithelioid cells and potentially giant cells.
Foreign-body granuloma
Inert / large material
No specific T-cell response required
Macrophages surround object
Immune granuloma
Persistent antigen
T-cell activation
Macrophage activation via cytokines
SCHEMATIC
Slide 55 · Th1–macrophage circuits can sustain granulomas
Antigen presentation and macrophage-derived cytokines stimulate T cells.
Th1-derived IFN-γ activates macrophages.
Continued interaction maintains the granulomatous response.
Antigen persistence
Macrophage presentation
Th1 / IFN-γ
Activated macrophages
↺ Reinforcing feedback
SCHEMATIC
Slide 56 · Granuloma formation is not necessarily harmless
Aggregation may help contain persistent injurious agents.
Activated macrophages also release tissue-injuring mediators.
The containment response can therefore distort or destroy tissue.
Protective aspect
Contain persistent agent
Focused cellular response
Potential cost
Local parenchymal injury
Architectural distortion / scarring
SCHEMATIC
Slide 57 · Persistent infection: A macrophage-centered example
Mycobacteria can evoke long-standing cell-mediated inflammation.
Th1 and macrophage responses may produce immune granulomas.
Morphologic recognition must prompt evaluation for an infectious cause.
Persistent microbe
T-cell / macrophage activation
Granulomatous inflammation
SCHEMATIC
Slide 58 · Silica exposure: The problem of a persistent particle
Particulate silica is an exogenous agent linked to chronic lung inflammation.
It is not readily degraded and may maintain tissue injury.
This illustrates why persistent material can sustain macrophage-rich inflammation.
Silica particles
Persistent lung stimulus
Chronic inflammatory response
SCHEMATIC
Slide 59 · Autoimmunity can perpetuate macrophage activation
Persistent immune recognition of self-antigens maintains inflammatory signaling.
Macrophages and lymphocytes can reinforce one another.
Tissue damage and later fibrosis are possible consequences.
Self-antigen response
Lymphocyte activation
Macrophage signaling
Tissue injury
↺ Reinforcing feedback
SCHEMATIC
Slide 60 · Macrophage-rich chronic lung injury: Interpreting a lesion
A chronic infiltrate should be evaluated together with parenchymal destruction.
Fibrosis indicates attempted repair and loss of architecture.
These findings form a pathologic pattern; They do not alone establish etiology.
Inflammatory cells
Destroyed alveolar structures
Fibrosis
SCHEMATIC
Slide 61 · Distinguish a chronic infiltrate from acute exudation
Acute inflammation typically emphasizes neutrophils, vascular changes and edema.
Chronic inflammation emphasizes mononuclear cells, damage and repair.
Mixed acute and chronic patterns occur, especially with repeated injury.
Acute pattern
Neutrophil-rich exudate
Edema / vascular change
Chronic pattern
Macrophages + lymphocytes
Tissue loss + fibrosis
SCHEMATIC
Slide 62 · Application: Persistent antigen and a T-cell loop
A lesion remains inflamed despite an extended host response.
Macrophages present antigen; T cells release IFN-γ.
Interpretation: Reciprocal activation can explain persistent macrophage activity.
Macrophage antigen display
Th1 activation
IFN-γ
Classical macrophage activation
↺ Reinforcing feedback
SCHEMATIC
Slide 63 · Application: Healing response becomes scarring
An injurious agent persists while macrophages remain activated.
Fibroblast stimulation and ECM deposition continue alongside injury.
Interpretation: Repair signaling may become pathologic fibrosis.
Persistent damage
Macrophage signals
Fibroblast activation
Fibrosis
SCHEMATIC
Slide 64 · Application: Interpret macrophage activation labels
A macrophage-rich lesion expresses inflammatory and reparative programs.
M1/M2 are useful functional shorthand but do not define rigid populations.
Interpretation: Macrophage states may be mixed and dynamic.
Local stimuli
Diverse macrophage states
Mixed functional outputs
SCHEMATIC
Slide 65 · Integrating macrophages into chronic inflammation
Origins and recruitment set the cells available within a lesion.
Activation signals determine inflammatory, microbicidal and reparative outputs.
Outcome reflects stimulus persistence, T-cell interactions and tissue response.
Origin + recruitment
Activation
Defense + injury + repair
Outcome
SCHEMATIC
Slide 66 · Final synthesis: Four mechanistic principles
Macrophages can be long-lived tissue residents or recruited monocyte descendants.
Activated cells destroy microbes and also risk collateral tissue damage.
Interactions with T lymphocytes help sustain chronic inflammation.
Macrophages coordinate repair; Persistent activation can lead to fibrosis.
Defense
Chronic injury
Repair / fibrosis
SCHEMATIC
Slide 67 · Reference
Robbins, Cotran & Kumar: Pathologic Basis of Disease
11th edition (2026)
Inflammation and Repair